跳至主要内容
临床试验/NCT00310479
NCT00310479已完成不适用

Clinico-pathologic Correlative Study of 3T Magnetic Resonance Spectroscopy in the Localization of Prostate Cancer

AHS Cancer Control Alberta2 个研究点 分布在 1 个国家目标入组 16 人开始时间: 2006年6月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
16
试验地点
2
主要终点
characteristic metabolic pattern of prostate cancer at 3Tesla

研究概览

简要总结

We seek to develop an advanced imaging approach to identifying and localizing prostate cancer. We believe that high field MRI (magnetic resonance imaging) has the potential to do this and we will endeavor to prove this by having patients with prostate cancer pre-operatively undergo a technique called magnetic resonance spectroscopy. After surgery, the microscopic locations of cancer will be compared with the pre-operative images to assess how well the imaging technique succeeds.

详细描述

The proposed research is enormously relevant to the clinical understanding of early prostate cancer. We propose to test to see whether characteristic patterns of invivo 3T MRSI associated metabolites can be identified in correlation with clinically active tumor reserved on histopathologic analysis of resected specimens. We also plan to demonstrate that 3T MR spectra of prostate cancer will allow for more detailed metabolic assessment with higher sensitivity, specificity and accuracy and publish results established from MR spectra using 1.5T MR units. Functional imaging (eg. molecular imaging such as this) is felt to be the clinical wave of the future for cancer imaging, and if successful, will assume a very major role in the detection, assessment, treatment planning and delivery of drugs, radiation, heat and novel therapeutics in the fight against prostate cancer.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
40 Years 至 —(Adult, Older Adult)
性别
Male
接受健康志愿者

入选标准

  • Histologically verified prostate cancer
  • Patient has opted for surgery
  • Low risk prostate cancer PSA <1 0, Gleason < 7, Stage < T2b
  • No contraindication to MR scanning
  • No prior history of malignancy
  • Fit for surgery

排除标准

  • Nonbiopsied lesion
  • Intermediate or high risk prostate cancer
  • Unfit for surgery
  • Contraindication to MR scanning (i.e. pacemaker, aneurysm clips, claustrophobia)

结局指标

主要结局

characteristic metabolic pattern of prostate cancer at 3Tesla

次要结局

  • PPV of MRS in the detection of prostate cancer
  • specificity, accuracy, NPV

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验